Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sigal

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Histopathology|July 29, 2004
Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breastX Sastre-Garau, P Genin, A Rousseau, et al.
Scientific Reports|May 11, 2024
Exploratory factor analysis yields grouping of brain injury biomarkers significantly associated with outcomes in neonatal and pediatric ECMOVictoria Huang, Jennifer Roem, Derek K Ng, et al.
Iscience|August 8, 2022
Elevation of neural injury markers in patients with neurologic sequelae after hospitalization for SARS-CoV-2 infectionMichail Spanos, Sigal Shachar, Thadryan Sweeney, et al.
Science (New York, N.Y.)|October 13, 1989
Detection of cell-affecting agents with a silicon biosensorJ W Parce, J C Owicki, K M Kercso, et al.
Radiation Protection Dosimetry|July 31, 2016
Non-human Primate Total-body Irradiation Model with Limited and Full Medical Supportive Care Including Filgrastim for Biodosimetry and Injury AssessmentNatalia I Ossetrova, William F Blakely, Vitaly Nagy, et al.
Plos One|April 19, 2019
Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patientsTobias Broger, Michael Tsionksy, Anu Mathew, et al.
Breast (Edinburgh, Scotland)|January 7, 2014
Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgeryE Guillot, C Vaysse, J Goetgeluck, et al.
Breast Cancer Research and Treatment|September 5, 2016
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapyA S Hamy, I Bieche, J Lehmann-Che, et al.
Clinical Chemistry and Laboratory Medicine|April 27, 2022
Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigensAntigona Ulndreaj, Mingyue Wang, Salvia Misaghian, et al.
Ebiomedicine|November 5, 2017
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical TrialG B Sigal, M R Segal, A Mathew, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Histopathology|July 29, 2004
Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breastX Sastre-Garau, P Genin, A Rousseau, et al.
Scientific Reports|May 11, 2024
Exploratory factor analysis yields grouping of brain injury biomarkers significantly associated with outcomes in neonatal and pediatric ECMOVictoria Huang, Jennifer Roem, Derek K Ng, et al.
Iscience|August 8, 2022
Elevation of neural injury markers in patients with neurologic sequelae after hospitalization for SARS-CoV-2 infectionMichail Spanos, Sigal Shachar, Thadryan Sweeney, et al.
Science (New York, N.Y.)|October 13, 1989
Detection of cell-affecting agents with a silicon biosensorJ W Parce, J C Owicki, K M Kercso, et al.
Radiation Protection Dosimetry|July 31, 2016
Non-human Primate Total-body Irradiation Model with Limited and Full Medical Supportive Care Including Filgrastim for Biodosimetry and Injury AssessmentNatalia I Ossetrova, William F Blakely, Vitaly Nagy, et al.
Plos One|April 19, 2019
Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patientsTobias Broger, Michael Tsionksy, Anu Mathew, et al.
Breast (Edinburgh, Scotland)|January 7, 2014
Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgeryE Guillot, C Vaysse, J Goetgeluck, et al.
Breast Cancer Research and Treatment|September 5, 2016
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapyA S Hamy, I Bieche, J Lehmann-Che, et al.
Clinical Chemistry and Laboratory Medicine|April 27, 2022
Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigensAntigona Ulndreaj, Mingyue Wang, Salvia Misaghian, et al.
Ebiomedicine|November 5, 2017
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical TrialG B Sigal, M R Segal, A Mathew, et al.
Pageof 9